Gene | ID | Name | Fold change | p value | FDR |
---|---|---|---|---|---|
A | |||||
TNFSF18 | 768,081 | tumor necrosis factor superfamily member 18 | 5.3 | 6.9 × 10−4 | 2.4 × 10− 2 |
Slc26a10 | 506,076 | solute carrier family 26 member 10 | 4.3 | 1.2 × 10−3 | 3.5 × 10− 2 |
NR4A1 | 528,390 | nuclear receptor subfamily 4 group A member 1, transcript variant X3 | 3.1 | 9.7 × 10−5 | 6.2 × 10− 3 |
IGFLR1 | 617,594 | IGF like family receptor 1 | 3.1 | 6.6 × 10−5 | 4.7 × 10−3 |
GSDMB | 509,296 | gasdermin B | 2.5 | 6.4 × 10−5 | 4.6 × 10−3 |
LBH | 616,148 | limb bud and heart development | 2.2 | 6.7 × 10−14 | 4.6 × 10− 10 |
LY6G5B | 539,236 | lymphocyte antigen 6 complex, locus G5B | 2.2 | 1.4 × 10−3 | 3.9 × 10− 2 |
MYOZ2 | 540,487 | myozenin 2, transcript variant X1 | 2.7 | 4.01 × 10−5 | 3.5 × 10−3 |
RRAD | 505,165 | Ras-related associated with diabetes | 2.0 | 5.8 × 10−5 | 4.3 × 10−3 |
PLAU | 281,983 | plasminogen activator, urokinase receptor | 1.7 | 4.6 × 10−8 | 2.1 × 10−5 |
B | |||||
CYP1A1 | 282,870 | cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1, transcript variant X2 | −2.8 | 4.3 × 10−10 | 6.6 × 10−7 |
CYP1B1 | 511,470 | cytochrome P450, family 1, subfamily B, polypeptide 1 | −2.4 | 2.0 × 10− 10 | 4.0 × 10−7 |
ID1 | 497,011 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | −2.4 | 3.5 × 10− 16 | 4.9 × 10− 12 |
GPR35 | 505,056 | G protein-coupled receptor 35, transcript variant X7 | − 2.4 | 2.4 × 10−4 | 1.2 × 10− 2 |
SLC25A34 | 515,553 | solute carrier family 25 member 34 | − 2.3 | 2.3 × 10−5 | 2.4 × 10− 3 |
EDN2 | 319,094 | endothelin 2, transcript variant X1 | − 2.1 | 3.4 × 10−8 | 1.7 × 10−5 |
ATOH8 | 616,225 | atonal bHLH transcription factor 8, transcript variant X1 | −2.1 | 5.1 × 10− 9 | 4.4 × 10− 6 |
ID3 | 538,690 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | −2.0 | 1.2 × 10− 12 | 5.8 × 10− 9 |
BDKRB1 | 532,119 | bradykinin receptor B1 | −1.9 | 1.1 × 10−4 | 6.7 × 10− 3 |